AAAAAA

   
Results: 1-13 |
Results: 13
THE 3-MONTH RECURRENCE AS A PROGNOSTIC FACTOR FOR THE LONG-TERM OUTCOME IN TATL BLADDER-CANCER - RESULTS OF A COMBINED ANALYSIS OF EORTC AND MRC RANDOMIZED TRIALS OF PROPHYLACTIC TREATMENT
Authors: COLLETTE L SYLVESTER RJ DENIS LJ BOUFFIOUX C KURTH K VANDERMEIJDEN AP PARMAR MKB PAWINSKI A
Citation: L. Collette et al., THE 3-MONTH RECURRENCE AS A PROGNOSTIC FACTOR FOR THE LONG-TERM OUTCOME IN TATL BLADDER-CANCER - RESULTS OF A COMBINED ANALYSIS OF EORTC AND MRC RANDOMIZED TRIALS OF PROPHYLACTIC TREATMENT, The Journal of urology, 159(5), 1998, pp. 540-540
PROSTATE-CANCER - TO SCREEN OR NOT TO SCREEN
Authors: BOUFFIOUX C
Citation: C. Bouffioux, PROSTATE-CANCER - TO SCREEN OR NOT TO SCREEN, European urology, 31, 1997, pp. 2-4
ADJUVANT CHEMOTHERAPY FOR SUPERFICIAL TRANSITIONAL-CELL BLADDER-CARCINOMA - LONG-TERM RESULTS OF A EUROPEAN ORGANIZATION FOR RESEARCH AND TREATMENT OF CANCER RANDOMIZED TRIAL COMPARING DOXORUBICIN, ETHOGLUCID AND TRANSURETHRAL RESECTION ALONE
Authors: KURTH K TUNN U AY R SCHRODER FH PAVONEMACALUSO M DEBRUYNE F TENKATE F DEPAUW M SYLVESTER R ESSED E CAUBERGH RV HOEKSTRA JW DEVOOGT HJ NEWLING DWW DEREIJKE TM MENSINK HJA GROEN JM JAKSE G LEISINGER HJ RICHARDS B ADIB RA ROBINSON M DENIS L BOUFFIOUX C SCHULMAN C CARPENTIER PJ
Citation: K. Kurth et al., ADJUVANT CHEMOTHERAPY FOR SUPERFICIAL TRANSITIONAL-CELL BLADDER-CARCINOMA - LONG-TERM RESULTS OF A EUROPEAN ORGANIZATION FOR RESEARCH AND TREATMENT OF CANCER RANDOMIZED TRIAL COMPARING DOXORUBICIN, ETHOGLUCID AND TRANSURETHRAL RESECTION ALONE, The Journal of urology, 158(2), 1997, pp. 378-384
CHEMORESECTION IN TA-T1 BLADDER-CANCER
Authors: BONO AV HALL RR DENIS L LOVISOLO JA SYLVESTER R HETHERINGTON J SCHROEDER FH KURTH KH MARECHAL JM BOUFFIOUX C HOEKSTRA W LANGENMEYER W RUTISHAUSER G JANKNEGT R WHELAN P CONSIDINE J
Citation: Av. Bono et al., CHEMORESECTION IN TA-T1 BLADDER-CANCER, European urology, 29(4), 1996, pp. 385-390
A DOSE-RESPONSE STUDY OF THE EFFECT OF FLUTAMIDE ON BENIGN PROSTATIC HYPERPLASIA - RESULTS OF A MULTICENTER STUDY
Authors: NARAYAN P TRACHTENBERG J LEPOR H DEBRUYNE FMJ TEWARI A STONE N DAS S JIMENEZCRUZ JF SHEARER R KLINGBERT I SCHELLHAMMER PF COSTELLO AJ ODONOGHUE N CRAWFORD D COLLSTE L",SCHULTZESEEMANN,"KIRKEMO A BADELAMANT R WENDEROTH UK BRAWER M BOUFFIOUX C MCLEOD DG FLANIGAN RC GONICK P BREUL J SCHICK E KREIGMAIR M",KRAMER,"FRICK J",KAULEN,"BAUER H JASKE G HENEY N
Citation: P. Narayan et al., A DOSE-RESPONSE STUDY OF THE EFFECT OF FLUTAMIDE ON BENIGN PROSTATIC HYPERPLASIA - RESULTS OF A MULTICENTER STUDY, Urology, 47(4), 1996, pp. 497-504
A COMBINED ANALYSIS OF ORGANIZATION-FOR-RESEARCH-AND-TREATMENT-OF-CANCER, AND MEDICAL-RESEARCH-COUNCIL RANDOMIZED CLINICAL-TRIALS FOR THE PROPHYLACTIC TREATMENT OF STAGE TAT1 BLADDER-CANCER
Authors: PAWINSKI A SYLVESTER R KURTH KH BOUFFIOUX C VANDERMEIJDEN A PARMAR MKB BIJNENS L
Citation: A. Pawinski et al., A COMBINED ANALYSIS OF ORGANIZATION-FOR-RESEARCH-AND-TREATMENT-OF-CANCER, AND MEDICAL-RESEARCH-COUNCIL RANDOMIZED CLINICAL-TRIALS FOR THE PROPHYLACTIC TREATMENT OF STAGE TAT1 BLADDER-CANCER, The Journal of urology, 156(6), 1996, pp. 1934-1940
A COMBINED ANALYSIS OF ORGANIZATION-FOR-RESEARCH-AND-TREATMENT-OF-CANCER, AND MEDICAL-RESEARCH-COUNCIL RANDOMIZED CLINICAL-TRIALS FOR THE PROPHYLACTIC TREATMENT OF STAGE TAT1 BLADDER-CANCER - REPLY
Authors: PAWINSKI A SYLVESTER R KURTH KH BOUFFIOUX C VANDERMEIJDEN A PARMAR MKB BIJNENS L
Citation: A. Pawinski et al., A COMBINED ANALYSIS OF ORGANIZATION-FOR-RESEARCH-AND-TREATMENT-OF-CANCER, AND MEDICAL-RESEARCH-COUNCIL RANDOMIZED CLINICAL-TRIALS FOR THE PROPHYLACTIC TREATMENT OF STAGE TAT1 BLADDER-CANCER - REPLY, The Journal of urology, 156(6), 1996, pp. 1941-1941
PHASE-II TRIALS IN TA, T1 BLADDER-CANCER - THE MARKER TUMOR CONCEPT
Authors: VANDERMEIJDEN APM HALL RR KURTH KH BOUFFIOUX C SYLVESTER R
Citation: Apm. Vandermeijden et al., PHASE-II TRIALS IN TA, T1 BLADDER-CANCER - THE MARKER TUMOR CONCEPT, British Journal of Urology, 77(5), 1996, pp. 634-637
FACTORS AFFECTING RECURRENCE AND PROGRESSION IN SUPERFICIAL BLADDER-TUMORS
Authors: KURTH KH DENIS L BOUFFIOUX C SYLVESTER R DEBRUYNE FMJ PAVONEMACALUSO M OOSTERLINCK W
Citation: Kh. Kurth et al., FACTORS AFFECTING RECURRENCE AND PROGRESSION IN SUPERFICIAL BLADDER-TUMORS, European journal of cancer, 31A(11), 1995, pp. 1840-1846
EFFICACY AND TOLERABILITY OF CASODEX IN PATIENTS WITH ADVANCED PROSTATE-CANCER
Authors: LUNGLMAYR G ALFTHAN O ALTWEIN JE BLACKLEDGE G BLACKLOCK NJ BONO A BOUFFIOUX C CHANNER K DEBRUYNE F DENIS L DISILVERIO F GRASSET D HAEFLINGER JM HARLAND S HEIJBROEK RP HOISAETER PA IVERSEN P JAEGER N KEUPPENS F KHOE GS KLARSKOV P KONTTURI M KUBER W KUMS JJM LARDENOYE JG LEDUC A LUNGLMAYR G MOEHRING K NEWLING D PAVONEMACALUSO M PERMI J RASMUSSEN F ROSSETTI SR SANDER S SARRAMON JP SMITH PH TVETER K TYRRELL CJ USAI E VALLANCIEN GMB VANCANGH PJ VARENHORST E WEISSBACH L WHELAN P WILLIAMS JL ZALCBERG J ZATTONI F DAWES PM
Citation: G. Lunglmayr et al., EFFICACY AND TOLERABILITY OF CASODEX IN PATIENTS WITH ADVANCED PROSTATE-CANCER, Anti-cancer drugs, 6(4), 1995, pp. 508-513
INTRAVESICAL ADJUVANT CHEMOTHERAPY FOR SUPERFICIAL TRANSITIONAL-CELL BLADDER-CARCINOMA - RESULTS OF 2 -ORGANIZATION-FOR-RESEARCH-AND-TREATMENT-OF-CANCER RANDOMIZED TRIALS WITH MITOMYCIN-C AND DOXORUBICIN COMPARING EARLY VERSUS DELAYED INSTILLATIONS AND SHORT-TERM VERSUS LONG-TERM TREATMENT
Authors: BOUFFIOUX C KURTH KH BONO A OOSTERLINCK W KRUGER CB DEPAUW M SYLVESTER R DENIS L NEWLING D HALL R BRESSEL M CASSELMAN J SMITH P ROBINSON M KEUPPENS F TOLLEY D JAKSE G BOLLACK C VERGISON B HOEKSTRA W DASILVA FC GROEN J RICHARDS B PAVONEMACALUSO M VANDERMEIJDEN A ZWARTENDIJK H JACOBI G VANCAUBERG R SCHRODER F HIRDES D LEISINGER H RIEDL H LUDWIG P ROOZENDAAL K MARECHAL L VANAUBEL O CONSIDINE J DEBRUYNE F CARREIRA F DEWALL D MENSINK H VIGGIANO G
Citation: C. Bouffioux et al., INTRAVESICAL ADJUVANT CHEMOTHERAPY FOR SUPERFICIAL TRANSITIONAL-CELL BLADDER-CARCINOMA - RESULTS OF 2 -ORGANIZATION-FOR-RESEARCH-AND-TREATMENT-OF-CANCER RANDOMIZED TRIALS WITH MITOMYCIN-C AND DOXORUBICIN COMPARING EARLY VERSUS DELAYED INSTILLATIONS AND SHORT-TERM VERSUS LONG-TERM TREATMENT, The Journal of urology, 153(3), 1995, pp. 934-941
EORTC(30885) RANDOMIZED PHASE-III STUDY WITH RECOMBINANT INTERFERON-ALPHA AND RECOMBINANT INTERFERON-ALPHA AND INTERFERON-GAMMA IN PATIENTSWITH ADVANCED RENAL-CELL CARCINOMA
Authors: DEMULDER PHM OOSTERHOF GON BOUFFIOUX C VANOOSTEROM AT VERMEYLEN K SYLVESTER R
Citation: Phm. Demulder et al., EORTC(30885) RANDOMIZED PHASE-III STUDY WITH RECOMBINANT INTERFERON-ALPHA AND RECOMBINANT INTERFERON-ALPHA AND INTERFERON-GAMMA IN PATIENTSWITH ADVANCED RENAL-CELL CARCINOMA, British Journal of Cancer, 71(2), 1995, pp. 371-375
A PLEA FOR COLD BIOPSY, FULGURATION AND IMMEDIATE BLADDER INSTILLATION WITH EPIRUBICIN IN SMALL SUPERFICIAL BLADDER-TUMORS - DATA FROM THE EORTC GU GROUP-STUDY 30863
Authors: OOSTERLINCK W SYLVESTER R HAMMOND B SCHRODER F VANAUBEL D MARECHAL JM NEWLING D KURTH KH VANPOPPEL H DEBRUYNE F VALLANCIEN G CASSELMAN J DEWALL J KARTHAUS P PAVONEMACALUSO M HALL R WALLACE D HANUS M BOEKENKRUGER C BOUFFIOUX C JANKNEGT RA BRESSEL M DEVOOGT H LANGEMEIJER T DENIS L GOMEZOLIVEIRA A VANDERMEIJDEN A CARPENTIER P HOEKSTRA J KEUPPENS F VANCANGH PJ STERNBERG C STOCKLE M RICHARDS B JAKSE G VANVELTHOVEN R RUTISHAUSER G AKDAS A
Citation: W. Oosterlinck et al., A PLEA FOR COLD BIOPSY, FULGURATION AND IMMEDIATE BLADDER INSTILLATION WITH EPIRUBICIN IN SMALL SUPERFICIAL BLADDER-TUMORS - DATA FROM THE EORTC GU GROUP-STUDY 30863, European urology, 23(4), 1993, pp. 457-459
Risultati: 1-13 |